LTR Pharma Balance Sheet Health

Financial Health criteria checks 6/6

LTR Pharma has a total shareholder equity of A$2.9M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$3.4M and A$428.5K respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$3.10m
EquityAU$2.94m
Total liabilitiesAU$428.54k
Total assetsAU$3.37m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: LTP's short term assets (A$3.4M) exceed its short term liabilities (A$428.5K).

Long Term Liabilities: LTP has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: LTP is debt free.

Reducing Debt: LTP had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LTP has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: LTP is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies